1. Home
  2. STTK vs RTC Comparison

STTK vs RTC Comparison

Compare STTK & RTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STTK
  • RTC
  • Stock Information
  • Founded
  • STTK 2016
  • RTC 2003
  • Country
  • STTK United States
  • RTC China
  • Employees
  • STTK N/A
  • RTC N/A
  • Industry
  • STTK Biotechnology: Pharmaceutical Preparations
  • RTC Specialty Chemicals
  • Sector
  • STTK Health Care
  • RTC Industrials
  • Exchange
  • STTK Nasdaq
  • RTC Nasdaq
  • Market Cap
  • STTK 173.6M
  • RTC 171.1M
  • IPO Year
  • STTK 2020
  • RTC N/A
  • Fundamental
  • Price
  • STTK $3.69
  • RTC $8.08
  • Analyst Decision
  • STTK Strong Buy
  • RTC
  • Analyst Count
  • STTK 3
  • RTC 0
  • Target Price
  • STTK $10.67
  • RTC N/A
  • AVG Volume (30 Days)
  • STTK 122.7K
  • RTC 14.7K
  • Earning Date
  • STTK 11-07-2024
  • RTC 01-01-0001
  • Dividend Yield
  • STTK N/A
  • RTC N/A
  • EPS Growth
  • STTK N/A
  • RTC N/A
  • EPS
  • STTK N/A
  • RTC N/A
  • Revenue
  • STTK $4,123,999.00
  • RTC $71,896,698.00
  • Revenue This Year
  • STTK $164.45
  • RTC N/A
  • Revenue Next Year
  • STTK N/A
  • RTC N/A
  • P/E Ratio
  • STTK N/A
  • RTC N/A
  • Revenue Growth
  • STTK 380.09
  • RTC N/A
  • 52 Week Low
  • STTK $1.33
  • RTC $2.48
  • 52 Week High
  • STTK $11.76
  • RTC $40.00
  • Technical
  • Relative Strength Index (RSI)
  • STTK 51.49
  • RTC 58.38
  • Support Level
  • STTK $3.63
  • RTC $6.74
  • Resistance Level
  • STTK $3.94
  • RTC $7.39
  • Average True Range (ATR)
  • STTK 0.23
  • RTC 0.63
  • MACD
  • STTK 0.06
  • RTC 0.07
  • Stochastic Oscillator
  • STTK 56.14
  • RTC 88.90

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.

About RTC Baijiayun Group Ltd.

Baijiayun Group Ltd is a ToB video cloud technology service provider that solves various pain points and needs in the field of video technology applications for enterprises. The group supplies energy for the digital development of enterprises through audio and video technology. The firm provides video technology solutions to enterprises and government agencies in various fields such as automobiles, finance, education, and medical care. Baijiayun has created three categories of product services namely video SaaS/PaaS business, video cloud products and software, and video system solutions. It has set up multiple R&D centers, branches, and offices across the country, enabling video technology to create industrial value and promote the development of the real economy.

Share on Social Networks: